Should Investors Consider Buying MEI Pharma (MEIP) Shares Now That Stifel Has Upgraded The Stock?

July 27, 2018 - By Megan Stone

MEI Pharma (MEIP) Stock Upgrade

In an analyst report issued to clients and investors earlier today, Stifel has increased shares of MEI Pharma (MEIP) to a solid “Buy” rating and has set an estimated 12-month target price per share of $7.0. MEIP’s rating before this upgrade was a “Hold”.

The stock increased 3.54% or $0.12 during the last trading session, reaching $3.51. About 314,369 shares traded. MEI Pharma, Inc. (MEIP) has risen 58.88% since July 27, 2017 and is uptrending. It has outperformed by 46.31% the S&P500.

Analysts await MEI Pharma, Inc. (NASDAQ:MEIP) to report earnings on September, 4. They expect $-0.24 EPS, down 100.00 % or $0.12 from last year’s $-0.12 per share. After $-0.16 actual EPS reported by MEI Pharma, Inc. for the previous quarter, Wall Street now forecasts 50.00 % negative EPS growth.

MEI Pharma, Inc., an oncology company, focuses on the clinical development of drugs for the treatment of cancer. The company has market cap of $246.85 million. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. It currently has negative earnings. The Company’s clinical development portfolio also includes ME-401, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia or follicular lymphoma; and ME-344, an isoflavone-derived mitochondrial inhibitor for the treatment of HER2-negative breast cancer.

More important recent MEI Pharma, Inc. (NASDAQ:MEIP) news were published by: which released: “MEI Pharma (MEIP) PT Raised to $6 at Oppenheimer” on July 09, 2018, also published article titled: “Premarket analyst action – healthcare”, published: “MEI Pharma (MEIP) Promotes David M. Urso to COO” on July 16, 2018. More interesting news about MEI Pharma, Inc. (NASDAQ:MEIP) was released by: and their article: “28 Stocks Moving In Monday’s Pre-Market Session” with publication date: July 02, 2018.

MEI Pharma, Inc. (NASDAQ:MEIP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.